Trends and perspectives in pancreas and simultaneous pancreas and kidney transplantation.
Pancreas transplantation is still the best option to achieve normoglycaemia and insulin independence in patients with type I diabetes. As a result of improvements in surgical techniques, immunosuppression and patient selection, one year survival rates of 95, 83, and 88% for patient, pancreas, and kidney survival, respectively, are reported for patients with simultaneous pancreas and kidney transplantation. The main goals for the future are to reduce postoperative morbidity, to identify the relevant indications for single pancreas transplantation, to adopt the best surgical technique for individual patients' needs (bladder versus enteric drainage with or without portal venous delivery of insulin), and to develop immunosuppressive strategies with low nephrotoxic and diabetogenic potential.
Departments of Nephrology and Medical Intensive Care, University Hospital Charité, Campus Virchow-Klinikum, Berlin, Germany. andreas.kahl@charite.de
A
A
Kahl
W O
WO
Bechstein
U
U
Frei
D006084:Graft Rejection / Q000175:diagnosis; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation / Q000379:methods / Q000401:mortality / Q000639:trends*; D016035:Pancreas Transplantation / Q000379:methods / Q000401:mortality / Q000639:trends*; D011183:Postoperative Complications / Q000453:epidemiology; D011788:Quality of Life; D015996:Survival Rate